Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.

Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.

Item
http://www.wikidata.org/entity/Q53136942
Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced LiverESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma.Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?Surrogate arterial phase imaging using a long duration (≈1.5 min) radial acquisition T1-weighted sequence: an alternative in patients unable to breath-hold.Inter- and intra-individual comparative study of two gadolinium-based agents: A pilot study.Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
P2860

Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.

Item
http://www.wikidata.org/entity/Q53136942
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@en
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@nl
type
label
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@en
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@nl
prefLabel
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@en
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Enhancement of the liver and p ...... Tesla MRI in the same patient.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921